Objective: The primary study objective is to establish the systemic exposure of consumers to PPD containing hair dye gel-based formulation under actual use conditions during a single typical hair dye procedure.
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
nvt. diit is een veiligheidsonderzoek
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Main study parameters/endpoints:
The individual concentration of [14C]-radioactivity (recoveries) in all
non-biological samples will be established and expressed as percentages
relative to the applied dose. For biological (blood and urinary) samples, the
individual concentration versus time courses of [14C]-radioactivity will be
established and expressed as percentages relative to the applied dose; results
will also be expressed as [14C]-PPDeq or as [14C]-PPDeq per unit of mass (g) or
volume (mL).
Secondary outcome
Establishing a Mass Balance
Background summary
Rationale: At present, despite the wide use of PPD, data on the extent of
systemic exposure of consumers to this active ingredient in hair dyes under
realistic use conditions is not available. Once knowledge on the extent of
systemic exposure under typical *in-use* conditions has been gained, the risk
for consumers using PPD-containing hair dye products can be assessed properly.
This study is set up:
- to gain realistic data and to get insight on the systemic exposure to PPD in
consumers (n=16), resulting from a single hair dye procedure with a reduced PPD
content (1% on head) performed by professional hairdressers under realistic
conditions;
- to establish a *mass balance*, since [14C]-radiolabelled PPD is used in this
study.
Study objective
Objective: The primary study objective is to establish the systemic exposure of
consumers to PPD containing hair dye gel-based formulation under actual use
conditions during a single typical hair dye procedure.
Study design
Study design: A single (topical) application, open study
Study approach: The systemic exposure derived from an oxidative hair dye
procedure is evaluated following a single controlled application performed by
professional hairdressers of a [14C]-labelled hair dye mixture onto the hair of
healthy subjects. Plasma and urinary levels of [14C]-PPD will give insight into
the extent of systemic exposure. A mass balance will also be established in the
study.
Intervention
Intervention: A single typical hair dye procedure per subject will be performed
by a professional hairdresser. Four professional hairdressers will be involved
in the study.
Study burden and risks
Nature and extent of the burden and risks associated with participation,
benefit and group relatedness: The maximum amount of [14C]-radioactivity
handled or to come in contact with will not exceed 3.6MBq per subject in this
study. This level of radioactivity is chosen to gain reliable data on the
systemic exposure of consumers to hair dyeing. Based on recent human data, the
physical-chemical properties of the active ingredient (not volatile), the skin
protection by gloves, the combined reaction with the coupler (irreversible
binding to the hair shaft), it is expected that the dermal and inhalation
exposure for the professional hairdresser will be low to negligible. The latter
was confirmed by the recently conducted and reported hairdresser exposure study
[2].
Possible skin contact with hair dye results in a radiation dose for the skin
and for the total body which is dependent on the fraction of radioactive
material to come in contact with skin, the fraction absorbed by the skin and
the penetration via the skin into the human body. Recently reported human data
in literature [1] show that the dermal penetration of PPD, directly in contact
for 30 minutes with bare skin, amounted on average to about 0.5% with a maximum
of 1.02%, expressed as percentage of the applied dose. Since in this study the
PPD content of the used hair dye formulation is reduced (1% instead of 2% on
head) the possible absorption is expected to be lower.
The Nuclear Research and Consultancy Group (NRG) has performed calculations on
the skin dose, the internal dose and the effective dose for an exposure
duration to the hair dye comparable to the daily life situation in hair dyeing
[3]. The effective radiation dose (body burden) per subject is estimated to be
maximally 0.025 mSv.
In conclusion, the radiation dose received by the subjects in this study will
be well below the Euratom dose limit (body burden; 0.025mSv) of 1mSv/year and
therefore their risk will only be slightly increased due to their participation
in this study.
Based on the fact that [14C] is a radiation emitter with low energy it is
concluded that risk for the professional hairdressers and workers in the
Clinical Research Unit is not enhanced.
Postbus 360
3700 AJ Zeist
Nederland
Postbus 360
3700 AJ Zeist
Nederland
Listed location countries
Age
Inclusion criteria
1:Female/Male; Age 18-45 years;
2:Healthy as assessed by health questionnaire, physical examination, clinical chemistry a pregnancy test in urine will be done.
3:Prescribed medication (oral contraceptives and paracetamol excluded)
4:Having given their written informed consent
5:Willing to have their coloured hair completely clipped (bald headed!)
6:Willing to refrain from blood donation during the whole study
7:Willing to use adequate measures to avoid pregnancy during the whole study (females only)
8:Willing to accept use of all anonymous data, including publication, and the confidential use and storage of all data
9: Willing to accept the disclosure of the financial benefit of participation in the study to the authorities concerned
10: Willing to refrain from hair cutting to let grow their hair to about a 5 cm length on day 01 of the study
Exclusion criteria
1:Participation in any clinical trial including blood sampling and/or administration of substances up to 90 days before Day 01 of this study
2:Participation in any clinical trial or medical treatment including administration of a radiolabelled test substance up to 1 year before Day 01 of this study
3: Positive pregnancy test (urine) (females) or lactating
4: Prescribed medication (except oral contraceptives and paracetamol)
5: Alcohol consumption more than 28 units/week (males) or 21 units/week (females); 1 unit of alcohol equals 10 grams of ethanol
6:Having a known allergy to PPD
7: Having a positive response to the retro-auricular sensitisation test to PPD, conducted 2 days in advance of Day 01 of the study
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL24586.028.08 |